A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis

被引:5
作者
Belaya, Zhanna [1 ]
Rozhinskaya, Liudmila [1 ]
Dedov, Ivan [1 ]
Drapkina, Oksana [2 ]
Fadeev, Valentin [3 ]
Golounina, Olga [3 ]
Lesnyak, Olga [4 ]
Mamedova, Elizaveta [1 ]
Melnichenko, Galina [1 ]
Petraikin, Alexey [5 ]
Rodionova, Svetlana [6 ]
Skripnikova, Irina [2 ]
Tkacheva, Olga [7 ]
Toroptsova, Natalia [8 ]
Yureneva, Svetlana [9 ]
Kanis, John A. [10 ,11 ]
机构
[1] Endocrinol Res Ctr, Neuroendocrinol & Bone Dis, Moscow, Russia
[2] Natl Med Res Ctr Therapy & Prevent Med, Moscow, Russia
[3] Sechenov Univ, IM Sechenov First Moscow State Med Univ, Dept Endocrinol, Minist Hlth Russian Federat, Moscow, Russia
[4] Western State Med Univ, Family Med Dept, St Petersburg, Russia
[5] Res & Pract Clin Ctr Diagnost, Dept Radiat Diagnost, Telemed Technol Moscow Hlth Care Dept, Moscow, Russia
[6] Ntl Med Res Ctr Traumatol & Orthoped, Moscow, Russia
[7] Russian Ntl Res Med Univ, Moscow, Russia
[8] VA Nasonova Res Inst Rheumatol, Moscow, Russia
[9] Natl Med Res Ctr Obstet, Dept Gynecol Endocrinol, Gynecol & Perinatol, Moscow, Russia
[10] Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia
[11] Univ Sheffield, Ctr Metab Bone Dis, Sheffield, England
关键词
Fragility fracture; FRAX; Osteoporosis; Russian clinical guidelines; BONE-MINERAL DENSITY; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; VERTEBRAL FRACTURE RISK; CORTICOSTEROID-INDUCED OSTEOPOROSIS; PARATHYROID-HORMONE (1-34); ZOLEDRONIC ACID TREATMENT; VITAMIN-D DEFICIENCY; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; HIP FRACTURE;
D O I
10.1007/s00198-022-06667-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Key statements of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis are summarized. They were developed by a task force representing the key Russian professional associations involved in the management of osteoporosis and approved by the Russian Ministry of Health.PurposeTo summarize key statements of the Russian clinical practice guidelines for the diagnosis and treatment of osteoporosis.MethodsThe Russian clinical guidelines on the diagnosis and treatment of osteoporosis were developed by a task force representing the key Russian professional associations involved in the management of osteoporosis: These comprised the Russian Association of Endocrinologists, the Russian Association for Osteoporosis, the Association of Rheumatologists of Russia, the Association of Orthopedic surgeons and Traumatologists of Russia, the Russian Association of Gynecologists-Endocrinologists, and the Russian Association of Gerontologists and Geriatrics. The guidelines are based on a systematic literature review and principles of evidence-based medicine and were compiled in accordance with the requirements for clinical recommendations developed by the Ministry of Health of the Russian Federation.ResultsKey statements included in the Russian guidelines of osteoporosis approved by the Russian Ministry of Health in 2021 are summarized. The statements are graded based on levels of evidence and supported by short comments. The guidelines are focused on the current approach to screening, diagnosis, differential diagnosis, and treatment of osteoporosis.ConclusionThese guidelines are a practical tool for general practitioners, as well as medical specialists, primarily endocrinologists, rheumatologists, orthopedic surgeons, and other physicians who are involved in the management of patients with osteoporosis.
引用
收藏
页码:429 / 447
页数:19
相关论文
共 195 条
  • [1] Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
    Adler, Robert A.
    El-Hajj Fuleihan, Ghada
    Bauer, Douglas C.
    Camacho, Pauline M.
    Clarke, Bart L.
    Clines, Gregory A.
    Compston, Juliet E.
    Drake, Matthew T.
    Edwards, Beatrice J.
    Favus, Murray J.
    Greenspan, Susan L.
    McKinney, Ross, Jr.
    Pignolo, Robert J.
    Sellmeyer, Deborah E.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (01) : 16 - 35
  • [2] Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle
    Akesson, K.
    Marsh, D.
    Mitchell, P. J.
    McLellan, A. R.
    Stenmark, J.
    Pierroz, D. D.
    Kyer, C.
    Cooper, C.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 (08) : 2135 - 2152
  • [3] Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis
    Amiche, M. A.
    Albaum, J. M.
    Tadrous, M.
    Pechlivanoglou, P.
    Levesque, L. E.
    Adachi, J. D.
    Cadarette, S. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 (06) : 1989 - 1998
  • [4] Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
    Anagnostis, Panagiotis
    Paschou, Stavroula A.
    Mintziori, Gesthimani
    Ceausu, Iuliana
    Depypere, Herman
    Lambrinoudaki, Irene
    Mueck, Alfred
    Perez-Lopez, Faustino R.
    Rees, Margaret
    Senturk, Levent M.
    Simoncini, Tommaso
    Stevenson, John C.
    Stute, Petra
    Tremollieres, Florence A.
    Goulis, Dimitrios G.
    [J]. MATURITAS, 2017, 101 : 23 - 30
  • [5] Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Makras, Polyzois
    Aubry-Rozier, Berengere
    Kaouri, Stella
    Lamy, Olivier
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (06) : 1291 - 1296
  • [6] [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1
  • [7] 2016 IMS Recommendations on women's midlife health and menopause hormone therapy
    Baber, R. J.
    Panay, N.
    Fenton, A.
    [J]. CLIMACTERIC, 2016, 19 (02) : 109 - 150
  • [8] Assessment of bone quality with trabecular bone score in type 2 diabetes mellitus: A study from the FRISBEE cohort
    Baleanu, Felicia
    Bergmann, Pierre
    Hambye, Anne Sophie
    Dekelver, Carole
    Iconaru, Laura
    Cappelle, Sylvie I.
    Moreau, Michel
    Paesmans, Marianne
    Karmali, Rafik
    Body, Jean-Jacques
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (05)
  • [9] Denosumab and bisphosphonates: Different mechanisms of action and effects
    Baron, Roland
    Ferrari, Serge
    Russell, R. Graham G.
    [J]. BONE, 2011, 48 (04) : 677 - 692
  • [10] Recommended testing in patients with low bone density
    Barzel, US
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) : 1404 - 1405